Congressional Trader
Live

GSK congressional trades

12 matched disclosures

Track congressional trades for GSK
Tracked disclosures
12
Lawmakers
5
Buy / sell
6 / 6
Avg post-trade move
N/A
Latest filing 2025-11-21

GSK congressional trades snapshot

This page summarizes public STOCK Act disclosures involving GSK. It is useful for seeing which lawmakers reported GSK transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Nov 21, 2025

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the GSK congressional trade page shows

Congressional Trader tracks 12 public STOCK Act disclosures for GSKacross 5 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent GSK filing shown here was filed on Nov 21, 2025 by Lisa C. McClain as a sale. Related lawmakers include Lisa C. McClain, Bruce Westerman, Val T. Hoyle, Marjorie Taylor Greene, Robert B. Aderholt.

Top lawmakers for GSK

Lisa C. McClain6 filingsBruce Westerman2 filingsVal T. Hoyle2 filingsMarjorie Taylor Greene1 filingsRobert B. Aderholt1 filings

Related paths

Alerts for GSKCongressional stock trading trackerLatest disclosures

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
Lisa C. McClainR-MIHouse
No committee data
Filed Nov 21, 2025
Delay 21 days
View filing
GSKNotable
GSK plc American Depositary Shares
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Lisa C. McClainR-MIHouse
No committee data
Filed Nov 21, 2025
Delay 22 days
View filing
GSKNotable
GSK plc American Depositary Shares
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Lisa C. McClainR-MIHouse
No committee data
Filed Nov 21, 2025
Delay 22 days
View filing
GSK
GSK plc American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Val T. HoyleD-ORHouse
No committee data
Filed Oct 10, 2025
Delay 17 days
View filing
GSK
GSK plc American Depositary Shares
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Lisa C. McClainR-MIHouse
No committee data
Filed Sep 12, 2025
Delay 39 days
View filing
GSK
GSK plc American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Val T. HoyleD-ORHouse
No committee data
Filed Sep 12, 2025
Delay 298 days
View filing
GSKNotable
GSK plc American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Robert B. AderholtR-ALHouse
No committee data
Filed Sep 10, 2025
Delay 44 days
View filing
GSK
plc American Depositary Shares
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Lisa C. McClainR-MIHouse
No committee data
Filed Aug 13, 2025
Delay 50 days
View filing
GSK
GSK plc American Depositary Shares
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Lisa C. McClainR-MIHouse
No committee data
Filed Aug 13, 2025
Delay 57 days
View filing
GSK
GSK plc American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Bruce WestermanR-ARHouse
No committee data
Filed May 12, 2025
Delay 21 days
View filing
GSK
GSK plc American Depositary Shares
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Bruce WestermanR-ARHouse
No committee data
Filed Apr 16, 2025
Delay 44 days
View filing
GSKNotable
GSK plc American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Marjorie Taylor GreeneR-GAHouse
No committee data
Filed Nov 27, 2024
Delay 2 days
View filing
GSKNotable
GSK plc American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded GSK?

Recent GSK disclosures include Lisa C. McClain, Bruce Westerman, Val T. Hoyle, Marjorie Taylor Greene, Robert B. Aderholt.

What is the buy/sell mix for GSK?

The visible sample currently shows 6 purchases and 6 sales or partial sales.

Should I trade based on GSK disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.